MarCom Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on MarCom Europe.

Press releases published on September 14, 2026

Sep. 14, 2026

Home Bancshares, Inc. Announces Third Quarter Earnings Release Date And Conference Call

Indeterminate GlobeNewswire

Sep. 14, 2026

Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards

Indeterminate GlobeNewswire

Sep. 14, 2026

byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination

Indeterminate GlobeNewswire

Sep. 14, 2026

Asha Peterson Launches KnowledgeRoots™ Media Center to Examine How Organizations Think, Operate, and Grow

Indeterminate EIN Presswire

Sep. 14, 2026

Toppoint Holdings Inc. Announces Anticipated Reincorporation from Nevada to Delaware

Indeterminate GlobeNewswire

Sep. 14, 2026

Frontier Nursing University Commencement to be Held September 19 at Rupp Arena

Indeterminate GlobeNewswire

Sep. 14, 2026

The St. Paul Phantom Hits #1 New Release on Amazon

Indeterminate GlobeNewswire

Sep. 14, 2026

Tired of Peeling - The Ultimate Guide to Achieving Perfect UV Ink Adhesion on Difficult Substrates | MYRIAD MINDED

Indeterminate EIN Presswire

Sep. 14, 2026

Host Hotels & Resorts Announces Third Quarter 2026 Earnings Call to be Held on November 5, 2026

Indeterminate GlobeNewswire

Sep. 14, 2026

DHT Holdings, Inc. secures three-year time charter for DHT Panther

Indeterminate GlobeNewswire

Sep. 14, 2026

CloudOffix Successfully Completes SOC 2 Type I Examination

Indeterminate EIN Presswire

Sep. 14, 2026

Yatra Issues Statement in Response to Magna’s Amendment and Extension of Its Unsolicited Tender Offer

Indeterminate GlobeNewswire

Sep. 14, 2026

EB5 Capital Announces the Completion of JF39 - Green House Gravity Apartments, Wellness-Focused Luxury Apartment Building in Columbus, Ohio

Indeterminate GlobeNewswire

Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire

Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire

Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire

Sep. 14, 2026

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Indeterminate GlobeNewswire

Sep. 14, 2026

A' Music, Audio and Sound Design Awards 2026 Call for Nominations Announced

Indeterminate EIN Presswire

Sep. 14, 2026

MYRIAD MINDED Showcases Custom DTF Ink for Epson at DPES Guangzhou and Shanghai APPPEXPO

Indeterminate EIN Presswire

Sep. 14, 2026

Censuswide launches new methodology to understanding what UK employer businesses really think

Indeterminate EIN Presswire